SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001178913-24-002186
Filing Date
2024-07-12
Accepted
2024-07-12 16:07:02
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A zk2431661.htm   iXBRL 20-F/A 59540
2 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 5268
3 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 5329
  Complete submission text file 0001178913-24-002186.txt   301881

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE trib-20231231.xsd EX-101.SCH 4824
5 XBRL DEFINITION FILE trib-20231231_def.xml EX-101.DEF 19844
6 XBRL LABEL FILE trib-20231231_lab.xml EX-101.LAB 27064
7 XBRL PRESENTATION FILE trib-20231231_pre.xml EX-101.PRE 22473
18 EXTRACTED XBRL INSTANCE DOCUMENT zk2431661_htm.xml XML 10020
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 000-22320 | Film No.: 241114532
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)